-+ 0.00%
-+ 0.00%
-+ 0.00%

Imuraya Group (TSE:2209) Stock Cheapens As Earnings Hold Firm

Simply Wall St·08/09/2026 00:30:00
语音播报

Imuraya Group came into this print looking like a steady value play in Japanese food, with the stock roughly flat over the past month and trading on a P/E below both the domestic food sector and the wider market. The headline from Q1 2027 is simple. Profit held up better than the share price action might suggest, with basic earnings per share at ¥17.74 and net income of ¥227 million helping lift trailing twelve month earnings to ¥190.28 per share.

Is Imuraya Group trading at a genuine discount on its 12.4x P/E, or does the DCF gap point to a stock that already prices in too much optimism? Compare the current market price with the detailed cash flow valuation in the valuation analysis for Imuraya Group

Q1 2027 Earnings Summary

  • Revenue, Q1 2027 vs. Q1 2026: ¥11,569 million vs. ¥10,848.278 million (year on year increase)
  • Net Income, Q1 2027 vs. Q1 2026: ¥227 million vs. ¥180.948 million (year on year improvement)
  • Basic EPS, Q1 2027 vs. Q1 2026: ¥17.74 vs. ¥14.14 (higher earnings per share year on year)
  • Trailing Twelve Month Basic EPS, Q1 2027 vs. Q1 2026: ¥190.28 vs. ¥170.35 (increase over the last year)

Tired of scrolling through dense earnings tables and raw figures to make sense of Imuraya Group? Get a simple, visual snapshot of the company, including its valuation picture, in the company report for Imuraya Group.

TSE:2209 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:2209 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Imuraya bullish signals in the latest earnings

For investors leaning toward the defensive consumer story, Imuraya Group offers some support. Revenue in Q1 2027 is higher than Q1 2026, and net income and basic EPS also sit above the prior year period. Trailing twelve month EPS of ¥190.28 is higher than a year ago, which fits a narrative of earnings resilience in everyday food products. The share price has drifted slightly over the past month while these core profit metrics have held up. That gap can appeal to investors who focus more on business performance than short term price moves.

Imuraya risks and what could worry bears

Bears can still point to a few caution flags around Imuraya Group. The share price has slipped over 7 and 30 days despite Q1 2027 showing higher revenue and earnings than Q1 2026. That hints at either lingering concern about future input costs or doubts about how repeatable the recent earnings level is. The small absolute size of quarterly net income, at ¥227 million, also leaves less room for error if costs rise or volumes soften. For now, the numbers soften the bear case rather than remove it.

With Imuraya Group trading on a discounted P/E while the share price sits above the provided DCF figure, the real tension is whether current profits are backed by balance sheet strength or fragile cash flows. Check the full debt, liquidity and cash runway breakdown in the financial health analysis of Imuraya Group stock

Stay Ahead With Simply Wall St

If Imuraya Group's steady earnings and current P/E have caught your eye, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value and wait for an entry point that fits your plan. After you own the stock, use the Portfolio Command Center to cut through noise and focus on the key updates that matter for your holdings. For a broader view, tap into what other investors are seeing and thinking through the Community so you can stress test your thesis. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond Imuraya Group?

Fresh stock ideas can move from under the radar to full breakout before the crowd catches on. Use these focused lists while it matters and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.